-
3 Emerging Markets Generics Company, Global Generics Leader and Active Ingredients Producer Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Dr. Reddy’s Laboratories and Laurus Labs
- October 28, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
No Comments
Emerging Market, Global Pharma and API Stocks with a strong future roadmap: Caplin Point Laboratories, Dr. Reddy’s Laboratories and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Branded Generics Exporter, Latin America Focused Drug Maker and Largest Indian Pharmaceutical Company Stocks With a Strong Future Roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma
- October 28, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Africa, Latin America and Specialty Drug Stocks with a strong future roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Generic Formulations Maker, Latin America Branded Generics Seller and Leading Chronic Therapy Pharma Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Caplin Point Laboratories and Torrent Pharmaceuticals
- October 28, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Chronic Therapy and Generic Formulation Stocks with a strong future roadmap: Alembic Pharmaceuticals, Caplin Point Laboratories and Torrent Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Latin America Branded Generics Seller, Over-the-Counter Formulations Exporter and Oncology and Complex Generics Maker Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Marksans Pharma and Natco Pharma
- October 27, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Emerging Market, OTC and Cancer Drug Stocks with a strong future roadmap: Caplin Point Laboratories, Marksans Pharma and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Latin America Branded Generics Seller, Research-Driven Pharma Company and Respiratory and Cardio Specialist Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Glenmark Pharmaceuticals and Lupin
- October 27, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Latin America and Respiratory Pharma Stocks with a strong future roadmap: Caplin Point Laboratories, Glenmark Pharmaceuticals and Lupin. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Cardiac and Gastro Brands Specialist, Latin America Generics Seller and Contract Formulations Maker Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Caplin Point Laboratories and Innova Captab
- October 26, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Brand, Latin America and Contract Pharma Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Caplin Point Laboratories and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Anti-Infective and Gastro Franchise, Latin America Branded Generics and Respiratory Leader Stocks With a Strong Future Roadmap: Alkem Laboratories, Caplin Point Laboratories and Cipla
- October 23, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Branded Pharma and Emerging Market Stocks with a strong future roadmap: Alkem Laboratories, Caplin Point Laboratories and Cipla. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.
-
3 Branded Generics, Fermentation-Based Ingredients and Latin America Generics Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories
- October 22, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Branded Generic and Ingredient Stocks with a strong future roadmap: Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Latin America Generics, Custom Synthesis Ingredients and Finished Dosages Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Divi’s Laboratories and Granules India
- October 22, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Emerging Market and API Pharma Stocks with a strong future roadmap: Caplin Point Laboratories, Divi’s Laboratories and Granules India. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Domestic Brand Leader, Latin America Generics and Process Chemistry Stocks With a Strong Future Roadmap: Mankind Pharma, Caplin Point Laboratories and Neuland Laboratories
- October 21, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Domestic and Export Pharma Stocks with a strong future roadmap: Mankind Pharma, Caplin Point Laboratories and Neuland Laboratories. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
- 1
- 2